SCHEMBL2140286

SCHEMBL2140286

OCCc1ccc2c(c1)CCCO2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 7/20 0.47
WNT3A P56704 7/20 0.47
PRKCI P41743 1/20 0.42
CLK1 P49759 1/20 0.41
DYRK1A Q13627 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
POLB P06746 2/20 0.41
ALDH1A1 P00352 2/20 0.41
RAB9A P51151 2/20 0.40
AXL P30530 1/20 0.40
MERTK Q12866 1/20 0.40
NPC1 O15118 1/20 0.40
NOTUM Q6P988 1/20 0.40
HTR1A P08908 1/20 0.39
SLC6A4 P31645 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALOX5 P09917 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
BACE1 P56817 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2035570 0.90 PRKCI (0.49) PRKCIDYRK1APOLBALDH1A1RAB9A
SCHEMBL29791018 0.90 PRKCI (0.49) PRKCIDYRK1APOLBALDH1A1RAB9A
SCHEMBL10366473 0.86 CTNNB1 (0.49) CTNNB1WNT3APRKCICLK1DYRK1A
SCHEMBL29828764 0.83 TAAR1 (0.53) CTNNB1WNT3APRKCICLK1DYRK1A
SCHEMBL16416836 0.83 CTNNB1 (0.43) CTNNB1WNT3APRKCICLK1DYRK1A
SCHEMBL12569413 0.83 TAAR1 (0.53) CTNNB1WNT3APRKCICLK1DYRK1A
SCHEMBL12447477 0.83 CTNNB1 (0.46) CTNNB1WNT3APRKCICLK1DYRK1A
Hydrochloric Acid SCHEMBL20562122 0.82 TAAR1 (0.51) CTNNB1WNT3APRKCICLK1DYRK1A
SCHEMBL9112990 0.81 CTNNB1 (0.43) CTNNB1WNT3APRKCICLK1DYRK1A
SCHEMBL80222 0.80 PRKCI (0.46) PRKCIPOLBALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664264-B2 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof RESEARCH DEVELOPMENT FOUNDATION (US) 2014-03-04 US disclosed
US-20120251616-A1 Tocopherols, Tocotrienols, Other Chroman and Side Chain Derivatives and Uses Thereof SANDERS BOB G (US) 2012-10-04 US disclosed
US-8148424-B2 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof RESEARCH DEVELOPMENT FOUNDATION (US) 2012-04-03 US disclosed
US-20100303899-A1 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF SANDERS BOB G 2010-12-02 US disclosed
US-7718814-B2 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof RESEARCH DEVELOPMENT FOUNDATION (US) 2010-05-18 US disclosed
EP-1115398-B1 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF RES DEV FOUNDATION (US) 2010-05-05 EP disclosed
US-7608638-B2 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof RESEARCH DEVELOPMENT FOUNDATION (US) 2009-10-27 US disclosed
US-20080161349-A1 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF RESEARCH DEVELOPMENT FOUNDATION (US) 2008-07-03 US disclosed
US-20080119514-A1 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF SANDERS BOB G 2008-05-22 US disclosed
EP-1254130-B1 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF RES DEV FOUNDATION (US) 2008-01-02 EP disclosed
WO-2003039461-A2 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF RESEARCH DEVELOPMENT FOUNDATION (US) 2003-05-15 WO disclosed
EP-1254130-A4 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF RES DEV FOUNDATION (US) 2003-04-23 EP disclosed
EP-1254130-A1 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF RESEARCH DEVELOPMENT FOUNDATION (US) 2002-11-06 EP disclosed
US-20020156024-A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof RESEARCH DEVELOPMENT FOUNDATION 2002-10-24 US disclosed
EP-1115398-A4 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF RES DEV FOUNDATION (US) 2002-10-16 EP disclosed
US-20020107207-A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof RESEARCH DEVELOPMENT FOUNDATION 2002-08-08 US disclosed
US-6417223-B1 ANTIPROLIFERATION AGENTS OR APOTOPSIS RESEARCH DEVELOPMENT FOUNDATION 2002-07-09 US disclosed
WO-2001058889-A1 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF RESEARCH DEVELOPMENT FOUNDATION (US) 2001-08-16 WO disclosed
EP-1115398-A1 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF RESEARCH DEVELOPMENT FOUNDATION (US) 2001-07-18 EP disclosed
WO-2000016772-A1 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF RESEARCH DEVELOPMENT FOUNDATION (US) 2000-03-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100303899-A1 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF TST, TXNRD3, TXNRD1 CTNNB1 3518/4885WNT3A 3986/4885PRKCI 4514/4885
US-20020156024-A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof HCCS, TTPA, TST CTNNB1 3070/4885WNT3A 3992/4885PRKCI 4403/4885
US-20020107207-A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof TST, HCCS, TXNRD3 CTNNB1 3078/4885WNT3A 3961/4885PRKCI 4466/4885
US-20080161349-A1 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF TST, TXNRD3, TXNRD1 CTNNB1 3488/4885WNT3A 4031/4885PRKCI 4510/4885
US-20080119514-A1 TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMAN AND SIDE CHAIN DERIVATIVES AND USES THEREOF TXN, TXN2, TTPA CTNNB1 786/4885WNT3A 2311/4885PRKCI 4027/4885
US-20120251616-A1 Tocopherols, Tocotrienols, Other Chroman and Side Chain Derivatives and Uses Thereof TST, TXNRD3, TXNRD1 CTNNB1 3518/4885WNT3A 3986/4885PRKCI 4514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.